1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Mobile Crisis Response Expansion & Development" is currently closed and not accepting applications.
Mobile Crisis Response Expansion & Development is sponsored by Kansas Department for Aging and Disability Services (KDADS) (administered by Sedgwick County COMCARE). This grant from KDADS supports statewide Community Mental Health Centers (CMHCs) and Certified Community Behavioral Health Clinics (CCBHCs) in developing and expanding 24/7/365 mobile behavioral health crisis services.
The goal is to provide life-saving mobile response to individuals in need.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Statewide Community Mental Health Centers (CMHCs) and Certified Community Behavioral Health Clinics (CCBHCs) in Kansas. Confirm the full requirements in the official notice before applying.
The published deadline was June 30, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Mobile Crisis Response Expansion & Development is funded by Kansas Department for Aging and Disability Services (KDADS) (administered by Sedgwick County COMCARE). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Kansas. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article